nivolumab

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer

Top Biomedical Science shared a post on X about a recent paper by Peter de Gooyer et al. published in Nature Medicine.

“Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial”

Authors: Peter de Gooyer, Yara Verschoor, Lauren van den Dungen, Jose van den Berg, Myriam Chalabi et al.

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer

“Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.”

Source: Top Biomedical Science/X